National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Closed Meetings, 15540-15541 [2016-06480]
Download as PDF
<![CDATA[
15540
Federal Register / Vol. 81, No. 56 / Wednesday, March 23, 2016 / Notices
jstallworth on DSK7TPTVN1PROD with NOTICES
applicant that is in the Federal Awardee
Performance and Integrity Information
System (FAPIIS) before making any
award in excess of the simplified
acquisition threshold (currently
$150,000) over the period of
performance. An applicant may review
and comment on any information about
itself that a federal awarding agency
previously entered. IHS will consider
any comments by the applicant, in
addition to other information in FAPIIS
in making a judgment about the
applicant’s integrity, business ethics,
and record of performance under federal
awards when completing the review of
risk posed by applicants as described in
45 CFR 75.205.
As required by 45 CFR part 75
Appendix XII of the Uniform Guidance,
non-federal entities (NFEs) are required
to disclose in FAPIIS any information
about criminal, civil, and administrative
proceedings, and/or affirm that there is
no new information to provide. This
applies to NFEs that receive federal
awards (currently active grants,
cooperative agreements, and
procurement contracts) greater than
$10,000,000 for any period of time
during the period of performance of an
award/project.
Mandatory Disclosure Requirements
As required by 2 CFR part 200 of the
Uniform Guidance, and the HHS
implementing regulations at 45 CFR part
75, effective January 1, 2016, the Indian
Health Service must require a nonfederal entity or an applicant for a
federal award to disclose, in a timely
manner, in writing to the IHS or passthrough entity all violations of federal
criminal law involving fraud, bribery, or
gratuity violations potentially affecting
the federal award.
Submission is required for all
applicants and recipients, in writing, to
the IHS and to the HHS Office of
Inspector General all information
related to violations of federal criminal
law involving fraud, bribery, or gratuity
violations potentially affecting the
federal award. 45 CFR 75.113.
Disclosures must be sent in writing to:
U.S. Department of Health and Human
Services, Indian Health Service,
Division of Grants Management, ATTN:
Robert Tarwater, Director, 5600 Fishers
Lane, Mailstop 09E70, Rockville,
Maryland 20857. (Include ‘‘Mandatory
Grant Disclosures’’ in subject line)
Ofc: (301) 443–5204
Fax: (301–594–0899
Email: Robert.Tarwater@ihs.gov
and
U.S. Department of Health and
Human Services, Office of Inspector
General, ATTN: Mandatory Grant
VerDate Sep<11>2014
15:26 Mar 22, 2016
Jkt 238001
Disclosures, Intake Coordinator, 330
Independence Avenue SW., Cohen
Building, Room 5527, Washington, DC
20201. URL: https://oig.hhs.gov/fraud/
reportfraud/index.asp. (Include
‘‘Mandatory Grant Disclosures’’ in
subject line)
Fax: (202) 205–0604 (Include
‘‘Mandatory Grant Disclosures’’ in
subject line) or
Email: MandatoryGranteeDisclosures@
oig.hhs.gov
Failure to make required disclosures
can result in any of the remedies
described in 45 CFR 75.371 Remedies
for noncompliance, including
suspension or debarment (See 2 CFR
parts 180 & 376 and 31 U.S.C. 3321).
VII. Agency Contacts
1. Questions on the programmatic
issues may be directed to: Jeremy
Marshall, Program Officer, Office of
Tribal Self-Governance, 5600 Fishers
Lane, Mail Stop: 08E05, Rockville, MD
20857. Phone: (301) 443–1912, Fax:
(301) 443–1050, Email:
Jeremy.Marshall@ihs.gov, Web site:
www.ihs.gov/self-governance.
2. Questions on grants management
and fiscal matters may be directed to:
Vanietta Armstrong, Grants
Management Specialist, 5600 Fishers
Lane, Mail Stop: 09E70, Rockville, MD
20857. Phone: (301) 443–4792, Fax:
(301) 594–0899, Email:
Vanietta.Armstrong@ihs.gov.
3. Questions on systems matters may
be directed to: Paul Gettys, Grant
Systems Coordinator, 5600 Fishers
Lane, Mail Stop: 09E70, Rockville, MD
20857. Phone: 301–443–2114; or the
DGM main line 301–443–5204, Fax:
(301) 594–0899, E-Mail: Paul.Gettys@
ihs.gov.
VIII. Other Information
The Public Health Service strongly
encourages all cooperative agreement
and contract recipients to provide a
smoke-free workplace and promote the
non-use of all tobacco products. In
addition, Public Law 103–227, the ProChildren Act of 1994, prohibits smoking
in certain facilities (or in some cases,
any portion of the facility) in which
regular or routine education, library,
day care, health care, or early childhood
development services are provided to
children. This is consistent with the
HHS mission to protect and advance the
physical and mental health of the
American people.
Dated: Macrch 17, 2016.
Elizabeth Fowler,
Deputy Director for Management Operations,
Indian Health Service.
[FR Doc. 2016–06556 Filed 3–22–16; 8:45 am]
BILLING CODE 4165–16–P
PO 00000
Frm 00043
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; Renal Disease
Ancillary Studies.
Date: April 13, 2016.
Time: 3:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892 (Telephone
Conference Call).
Contact Person: Carol J. Goter-Robinson,
Ph.D., Scientific Review Officer, Review
Branch, DEA, NIDDK, National Institutes of
Health, Room 7347, 6707 Democracy
Boulevard, Bethesda, MD 20892–5452, (301)
594–7791, goterrobinsonc@
extra.niddk.nih.gov.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; Loan Repayment
Application Review.
Date: April 14, 2016.
Time: 2:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892 (Telephone
Conference Call).
Contact Person: John F. Connaughton,
Ph.D., Chief, Training and Mentored
Research Section, Review Branch, DEA,
NIDDK, National Institutes of Health, Room
7007, 6707 Democracy Boulevard, Bethesda,
MD 20892–5452, (301) 594–7797,
connaughtonj@extra.niddk.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.847, Diabetes,
Endocrinology and Metabolic Research;
93.848, Digestive Diseases and Nutrition
Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes
of Health, HHS)
E:\FR\FM\23MRN1.SGM
23MRN1
15541
Federal Register / Vol. 81, No. 56 / Wednesday, March 23, 2016 / Notices
Dated: March 17, 2016.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2016–06480 Filed 3–22–16; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Proposed Collection; 60-Day Comment
Request Autism Spectrum Disorder
(ASD) Research Portfolio Analysis,
NIMH
Summary: In compliance with the
requirement of Section 3506(c)(2)(A) of
the Paperwork Reduction Act of 1995,
for opportunity for public comment on
proposed data collection projects, the
National Institute of Mental Health
(NIMH), National Institutes of Health
(NIH), will publish periodic summaries
of proposed projects to be submitted to
the Office of Management and Budget
(OMB) for review and approval.
Written comments and/or suggestions
from the public and affected agencies
are invited on one or more of the
following points: Whether the proposed
collection of information is necessary
for the proper performance of the
function of the agency, including
Proposed Collection: Autism
Spectrum Disorder (ASD) Research
Portfolio Analysis, 0925–0682,
Expiration Date 9/30/2016,
EXTENSION, National Institute of
Mental Health (NIMH), National
Institutes of Health (NIH).
Need and Use of Information
Collection: The purpose of the ASD
portfolio analysis is to collect research
funding data from U.S. and
international ASD research funders, to
assist the Interagency Autism
Coordinating Committee (IACC) in
fulfilling the requirements of the
Combating Autism Act, and to inform
the committee and interested
stakeholders of the funding landscape
and current directions for ASD research.
Specifically, these analyses will
continue to examine the extent to which
current funding and research topics
align with the IACC Strategic Plan for
ASD Research. The findings will help
guide future funding priorities by
outlining current gaps and opportunities
in ASD research as well as serving to
highlight annual activities and research
progress.
OMB approval is requested for three
years. There are no costs to respondents
other than their time. The total
estimated annualized burden hours are
520.
whether the information will have
practical utility; the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
ways to enhance the quality, utility, and
clarity of the information to be
collected; and ways to minimize the
burden of the collection of information
on those who are to respond, including
the use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology.
To Submit Comments and for Further
Information: To obtain a copy of the
data collection plans and instruments,
submit comments in writing, or request
more information on the proposed
project, contact: The Office of Autism
Research Coordination, NIMH, NIH,
Neuroscience Center, 6001 Executive
Blvd., MSC 9663, Room 6184, Bethesda,
Maryland 20892, Or you can Email your
request, including your address to:
iaccpublicinquiries@mail.nih.gov.
Formal requests for additional plans and
instruments must be requested in
writing.
Comment Due Date: Comments
regarding this information collection are
best assured of having their full effect if
received within 60 days of the date of
this publication.
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Type of respondent
Average
burden per
response
(in hours)
Number of
responses per
respondent
Total annual
burden hour
U.S. Federal .....................................................................................................
U.S. Private ......................................................................................................
International Government ................................................................................
International Private .........................................................................................
22
8
4
4
63
75
14
9
15/60
15/60
15/60
15/60
347
150
14
9
Total ..........................................................................................................
38
2078
........................
520
Dated: March 17, 2016.
Melba Rojas,
Project Clearance Liaison, NIMH, NIH.
[FR Doc. 2016–06483 Filed 3–22–16; 8:45 am]
jstallworth on DSK7TPTVN1PROD with NOTICES
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Proposed Collection; 60-Day Comment
Request Surveys and Interviews to
Support an Evaluation of the
Innovative Molecular Analysis
Technologies (IMAT) Program (NCI)
In compliance with the
requirement of Section 3506(c)(2)(A) of
the Paperwork Reduction Act of 1995,
for opportunity for public comment on
proposed data collection projects, the
National Cancer Institute (NCI),
National Institutes of Health (NIH), will
publish periodic summaries of proposed
SUMMARY:
VerDate Sep<11>2014
15:26 Mar 22, 2016
Jkt 238001
PO 00000
Frm 00044
Fmt 4703
Sfmt 4703
projects to be submitted to the Office of
Management and Budget (OMB) for
review and approval.
Written comments and/or suggestions
from the public and affected agencies
are invited to address one or more of the
following points: (1) Whether the
proposed collection of information is
necessary for the proper performance of
the function of the agency, including
whether the information will have
practical utility; (2) The accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used; (3)
The quality, utility, and clarity of the
information to be collected; and (4)
Minimize the burden of the collection of
E:\FR\FM\23MRN1.SGM
23MRN1
]]>Agencies
[Federal Register Volume 81, Number 56 (Wednesday, March 23, 2016)]
[Notices]
[Pages 15540-15541]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-06480]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and Digestive and Kidney Diseases;
Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Diabetes and Digestive
and Kidney Diseases Special Emphasis Panel; Renal Disease Ancillary
Studies.
Date: April 13, 2016.
Time: 3:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Two Democracy Plaza, 6707
Democracy Boulevard, Bethesda, MD 20892 (Telephone Conference Call).
Contact Person: Carol J. Goter-Robinson, Ph.D., Scientific
Review Officer, Review Branch, DEA, NIDDK, National Institutes of
Health, Room 7347, 6707 Democracy Boulevard, Bethesda, MD 20892-
5452, (301) 594-7791, goterrobinsonc@extra.niddk.nih.gov.
Name of Committee: National Institute of Diabetes and Digestive
and Kidney Diseases Special Emphasis Panel; Loan Repayment
Application Review.
Date: April 14, 2016.
Time: 2:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Two Democracy Plaza, 6707
Democracy Boulevard, Bethesda, MD 20892 (Telephone Conference Call).
Contact Person: John F. Connaughton, Ph.D., Chief, Training and
Mentored Research Section, Review Branch, DEA, NIDDK, National
Institutes of Health, Room 7007, 6707 Democracy Boulevard, Bethesda,
MD 20892-5452, (301) 594-7797, connaughtonj@extra.niddk.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.847,
Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive
Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes of Health, HHS)
[[Page 15541]]
Dated: March 17, 2016.
David Clary,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2016-06480 Filed 3-22-16; 8:45 am]
BILLING CODE 4140-01-P
